Another important drawback of mAbs is their large size of ∼150 kDa, which can result in ineffective tumor penetration and ultimately inaccurate measurement of PD-1/PD-L1 expression levels when used as an imaging tracer (232). The gene discussed is PDCD1; the disease is neoplasm.